Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
UBS
US Department of Justice
Merck
Colorcon
Cipla
Julphar
Citi
Fuji

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078957

« Back to Dashboard
NDA 078957 describes STAVUDINE, which is a drug marketed by Cipla Ltd, Hetero Labs Ltd Iii, Mylan, Aurobindo Pharma, and Mylan Labs Ltd, and is included in six NDAs. It is available from eight suppliers. Additional details are available on the STAVUDINE profile page.

The generic ingredient in STAVUDINE is stavudine. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the stavudine profile page.

Summary for NDA: 078957

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details

Pharmacology for NDA: 078957

Suppliers and Packaging for NDA: 078957

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
STAVUDINE
stavudine
CAPSULE;ORAL 078957 ANDA KAISER FOUNDATION HOSPITALS 0179-0028 0179-0028-70 30 CAPSULE in 1 BOX, UNIT-DOSE (0179-0028-70)
STAVUDINE
stavudine
CAPSULE;ORAL 078957 ANDA Camber Pharmaceuticals, Inc. 31722-515 31722-515-01 100 CAPSULE in 1 BOTTLE (31722-515-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength15MG
Approval Date:Dec 29, 2008TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Dec 29, 2008TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength30MG
Approval Date:Dec 29, 2008TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Merck
Teva
Fuji
Chubb
Daiichi Sankyo
Johnson and Johnson
US Department of Justice
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot